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In contrast to epithelial cells, cardiomyocytes are connected by complex hybrid-type adher-
ing junctions, termed composite junctions (areae compositae). Composite junctions are
found to be composed of typical desmosomal as well as adherens junction proteins.There-
fore, in adult mammalian cardiomyocytes desmosomal proteins are not restricted to the
relatively small desmosomes but are indirectly involved in anchoring the myoﬁbrillar actin
ﬁlaments. Subsequent investigations revealed that the formation of composite junctions
is a rather late event during mammalian heart development and vertebrate heart evolution.
Nascent, more round shaped cardiomyocytes of early developmental stages are connected
by desmosomes and separate adherens junctions quite similar to cells of epithelial origin.
During progression of development both types of adhering junctions seem to gradually
fuse at the two poles of the mature mammalian cardiomyocytes to establish the hybrid-
type composite junctions. Recently, we demonstrated that the specialized cardiomyocytes
of the cardiac conduction system exhibit high amounts of desmosomes, not fully estab-
lished composite junctions and adherens junctions. This underlines the fact that cells of
the cardiac conduction system are known to resemble cardiomyocytes in their nascent
state and do not undergo working myocardial differentiation. However, the astonishing
high amount of desmosomal protein containing adhering junctions connecting, e.g., Purk-
inje ﬁbers raises the possibility that pacemaker and conductive tissue may be affected by
desmosomal gene mutations in ARVC/D patients.
Keywords: desmosome, area composita, heart, desmosomal gene mutation, conduction system,ARVC/D
EFFECTS OF MUTATIONS IN GENES ENCODING FOR
CARDIOMYOCYTE ADHERING JUNCTION COMPONENTS
Desmosomes and fasciae adhaerentes (sing., fascia adhaerens), the
latter also termed adherens junctions are responsible for cell–
cell adhesion and are often subsumed under the collective term
adhering junctions. In various epithelia, like in the multistratiﬁed
skin epithelium, desmosomes, and adherens junctions are distinct
structures with only few shared components, such as, e.g., plako-
globin (Cowin et al., 1986). Desmosomes anchor the cytoskeletal
intermediate ﬁlaments and fasciae adhaerentes the cytoskeletal
actin microﬁlaments (Franke, 2009; Dubash and Green, 2011).
In the heart things are quite different and more complex. Adult
mammalian cardiomyocytes are for the most part connected by
adhering junctions termed areae compositae (sing.,area composita)
or composite junctions to highlight their hybrid character (Franke
et al., 2006, 2009; Pieperhoff et al., 2010a). Composite junctions
consist of both, typical desmosomal and typical adherens junction
proteins (Franke et al., 2006; Pieperhoff et al., 2010a). In composite
junctions desmosomal proteins are therefore indirectly involved
in supporting the myoﬁbrillar actin anchorage in N-cadherin
mediated cell–cell adhesion complexes (Goossens et al., 2007).
Today it is generally accepted that arrhythmogenic right ven-
tricular cardiomyopathy/dysplasia (ARVC/D) is in most of the
cases caused by mutations in desmosomal genes. Disease causing
mutations have been found in genes encoding for the desmosomal
plaque components plakophilin-2, desmoplakin, and plakoglobin
and the transmembrane desmosomal cadherins desmoglein-2 and
desmocollin-2 (see, e.g., Rampazzo et al., 2002; Norman et al.,
2005; Pilichou et al., 2006; Thiene et al., 2007; for further references
please see Rickelt and Pieperhoff, 2012). Although rare,mutations
in some non-desmosomal proteins such as, desmin (see Figure 1),
transforming growth factor-β3 (TGFB3), transmembrane protein
43 (TMEM43), ryanodine receptor 2 (RYR2), laminsA and C, stri-
atin and titin have also been associatedwithARVC/Ddevelopment
(Rampazzo et al., 1995; Beffagna et al., 2005; Merner et al., 2008;
Klauke et al., 2010; Meurs et al., 2010; Quarta et al., 2011; Taylor
et al., 2011). ARVC/D is characterized by a progressive replace-
ment of contractile heart muscle tissue by ﬁbrotic and fat tissue
(“ﬁbrofatty replacement”) and severe arrhythmogenesis often fol-
lowed by sudden cardiac mortality. Fibrofatty replacement was
often but not exclusively found in the right ventricle (Bauce et al.,
2005; Lindstrom et al., 2005; Thiene et al., 2007). Homozygous
mutations in plakoglobin cause a syndromic disease form called
“Naxos disease” involving skin and hair abnormalities in addition
to the ARVC/D-type ﬁbrofatty replacement of the myocardium
(Protonotarios et al., 2001).
Functional alterations in ARVC/D most likely include alter-
ations in gap junctions and sodium channels as a result from
adhering junction defects (Kaplan et al., 2004; Sato et al., 2009,
2011). Furthermore, suppressed Wnt-signaling by nuclear plako-
globin may be involved in ﬁbrofatty replacement and ARVC/D
phenotype development (Garcia-Gras et al., 2006; MacRae et al.,
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2006; Hirschy et al., 2010; Lombardi et al., 2011). In earlier
investigations, cell contacts have been found to be an indepen-
dent factor for cardiomyocyte survival in vitro (Clark et al., 1998)
showing the general importance of these structures beside their
important role in cell–cell adhesion.
Overexpression of mutant desmosomal genes or introduction
of mutant desmosomal genes in mice (Pilichou et al., 2009) and
other animal model systems (zebraﬁsh) will help further to under-
standARVC/D disease development and treatment (Macrae, 2010;
Fabritz et al., 2011).
Recently, screening for novel candidates of ARVC/D caus-
ing genes have been for the ﬁrst time extended to typical fascia
adhaerens components, yet without striking results (Christensen
et al., 2011). However,many other candidate genes, localized in the
composite junctions within the intercalated disk may be included
in future screenings (e.g., Kargacin et al., 2006; Otten et al., 2010;
Seeger et al., 2010). Hopefully, this will improve molecular diag-
nostics, genetic testing, and genetic management of this disease
(Fressart et al., 2010).
POSSIBLE EFFECTS OF ARVC/D CAUSING GENE MUTATIONS
ON CELLS OF THE CARDIAC CONDUCTION SYSTEM
In the higher vertebrate heart muscle the rhythmic contraction of
single cardiomyocytes is secured by a hierarchical system which
includes the cardiac conduction system composed of pacemaker
and conductive tissue. Pacemaker and conductive tissue consists
of specialized cardiomyocytes which did not underwent working
myocardial differentiation (Christoffels et al., 2010). Cells of the
cardiac conduction system are insulated by connective tissue from
the working myocardium in some areas of the heart (see Figure 1;
see also, Anderson et al., 2009; Pieperhoff et al., 2010b). Electrical
impulses are generated by cells of the sinoatrial (SA) node and
travel to the atrioventricular (AV) node (Bakker et al., 2010). The
conduction velocity is greatly reduced in the AV node to allow
the atrium to contract before the ventricle (Mamlin and Fisch,
1965). The fast conduction system within the ventricle includes
the bundles of His (1893), the right and left bundle branches (RBB,
LBB) on either side of the ventricular septum and the meshwork
of Purkinje ﬁbers (Purkyne, 1845; Tawara, 1906; Shimada et al.,
2004; Miquerol et al., 2011).
Pathological alterations in the cardiac conduction system have
been described to cause sudden cardiac death before (e.g., Thiene
et al., 1983) but never been found nor described in cases of
ARVC/D. However, risk stratiﬁcation of ARVC/D patients using
ECGanalyses revealed that“prolongedPR interval,prolongedQRS
in lead VI, and presence of bundle branch block were predictors
for adverse outcome” (Lemola et al., 2005).
Conductive cells have been found to be connected by a relatively
high density of desmosomal protein containing desmosomes and
composite junctions (Pieperhoff et al., 2010b). Cell contacts of
conductive cells resemble adhering junctions of nascent cardiomy-
ocytes (Pieperhoff and Franke, 2007; Pieperhoff et al., 2010b).
Desmocollin-2 and desmoplakin (see Figure 2) and all other
desmosomal as well as adherens junction components involved
in connecting cardiomyocytes can be found in adhering junc-
tions of Purkinje ﬁber cells (Pieperhoff et al., 2010b). This is why,
mutations in desmosomal (and non-desmosomal) genes resulting
FIGURE 1 | Shown is a cryostat cross-section through ovine Purkinje
fibers. Double label immunoﬂuorescence microscopy was performed with
antibodies to desmin (red) and vimentin (green) in addition to nuclear DAPI
staining (blue). Note that the insulating connective tissue is strongly
positive for vimentin, whereas Purkinje ﬁbers are positive for desmin similar
to cardiomyocytes of the working myocardium. For experimental details
please see Pieperhoff et al. (2010b).
FIGURE 2 | Cryostat sections through ovine (A–C) and bovine (D)
Purkinje fibers. (A–C) Double label immunoﬂuorescence microscopy with
antibodies to desmoplakin [red (A) and β-catenin green (B)]. The overlay of
(A) and (B) is shown in (C) in addition to nuclear DAPI staining (blue). Note
the often dotted staining pattern but high abundance of the desmosomal
plaque component desmoplakin in conductive cells of the Purkinje ﬁbers.
(D) Desmocollin-2 antibody labeling (red) and DAPI staining (blue) merged
with the phase contrast image. The white dashed lines demarcate the
border between conductive tissue and insulating connective tissue. See
also Pieperhoff et al. (2010b).
in the described defects in the myocardium could affect cells of the
cardiac conduction system similarly. This could then contribute
to severe arrhythmogenesis in ARVC/D patients and may explain
why the presence of left bundle branch blocks in ECG analyses
has been found to be a predictor for the adverse outcome of the
disease (Lemola et al., 2005). Possible disease mechanisms could
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include cell adhesion defects, alterations in gap junction localiza-
tion and function, resulting conduction disturbance and ﬁbrofatty
replacement of cardiomyocytes of the conduction system as sim-
ilarly described in cardiomyocytes of the working myocardium
(Norgett et al., 2000; Norman et al., 2005; MacRae et al., 2006;
Herren et al., 2009; Sato et al., 2011).
SUMMARY AND CONCLUSION
Cardiomyocytes of the working myocardium and of the cardiac
conduction system share many similarities. The high abundance
of desmosomal protein containing adhering junctions connecting
cardiomyocytes of the conduction system raises the possibility that
conductive and pacemaker tissue might be affected by desmoso-
mal gene mutations in cases of ARVC/D. Even minor alterations in
cells of the cardiac conduction system could contribute to severe
arrhythmogenesis in ARVC/D patients.
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